Corveus Medical

Corveus Medical is a medical device company based in Houston, Texas, founded in 2021. It specializes in developing a minimally invasive, catheter-based solution for treating chronic heart failure, particularly for patients with moderate symptoms who have limited treatment options. The company was co-founded by physician Ishan Kamat and medical device expert Tyler Melton. Corveus Medical is recognized as a Fogarty Innovation-backed startup and participated in the Y Combinator Winter 2022 batch. The core product is a catheter-based neuromodulation device designed for targeted nerve ablation in the upper abdomen. This device utilizes the body's venous anatomy to reach and deactivate a specific sympathetic nerve branch that contributes to heart failure progression. Key features include a minimally invasive approach that reduces procedural risk, targeted nerve ablation that minimizes collateral tissue damage, and real-time confirmation of nerve deactivation during procedures. Corveus Medical aims to improve patient outcomes by providing cardiologists and healthcare providers with innovative treatment options for chronic heart failure.

• Employees 3